Acute myocardial infarction (AMI) can be complicated by several forms of pericarditis, distinguished by their timing and pathogenetic mechanism.
In addition to cardiac rupture with acute pericardial hemorrhage and cardiac tamponade, the main types of post-infarction pericarditis are:
Epistenocardial pericarditis: occurs early, between the 2nd and 4th day after infarction, as an inflammatory reaction to myocardial necrosis. It has an incidence of 5-10% in infarcted patients and presents with a mild fibrinous effusion, generally of little clinical significance.
Dressler's syndrome: a late autoimmune pericarditis, arising between the 2nd and 6th week post-infarction. It may be associated with pleuritis and is characterized by exudative effusion, fever, malaise, leukocytosis and elevated inflammatory markers. It is often accompanied by pleuritic chest pain and transient pulmonary infiltrates.
Diagnosis:
both forms are identified by ECG, which may show diffuse ST-segment changes (superimposed on those of AMI), and by echocardiography, which is useful for assessing the presence of pericardial effusion.
Treatment:
management is based on NSAIDs (ibuprofen or aspirin) and colchicine to reduce the risk of recurrence. Corticosteroids are reserved for resistant cases or those with multiple recurrences.
TRAUMATIC PERICARDITIS
Traumatic pericarditis develops following trauma involving the pericardium, predominantly of hemorrhagic type.
Main causes:
Penetrating chest trauma: stab or gunshot wounds, with high risk of hemopericardium and cardiac tamponade.
Blunt chest trauma: road accidents (steering wheel impact), falls from great heights, explosions.
Abdominal trauma: sudden increase in abdominal pressure transmitted to the pericardium.
Traumatic pericarditis generally presents with late-onset chest pain (3-4 weeks after trauma), associated with high fever, leukocytosis and elevated ESR. In severe cases, it may progress to constrictive pericarditis.
Diagnosis:
ECG: ST-segment and T-wave abnormalities, with voltage reduction in case of hemopericardium.
Chest X-ray: useful for identifying rib fractures and indirect signs of pericardial effusion.
Echocardiography: gold standard for detecting pericardial fluid.
Treatment:
Observation and anti-inflammatory therapy (NSAIDs, colchicine) in mild cases.
Pericardiocentesis in cases of large effusions or suspected cardiac tamponade.
Pericardiectomy in rare cases of secondary constrictive pericarditis.
DRUG-INDUCED PERICARDITIS
Certain drugs can induce pericarditis as an adverse effect, either through a hypersensitivity mechanism or a direct toxic effect on the pericardium.
Most frequently implicated drugs:
Procainamide (antiarrhythmic) → associated with pericarditis within the spectrum of drug-induced lupus syndrome.
Hydralazine (antihypertensive) → can cause an immune-mediated pericarditis similar to SLE.
Penicillin (antibiotic) → hypersensitivity reaction with pericardial inflammation.
Phenylbutazone (NSAID) → withdrawn from the market in many countries due to high systemic toxicity.
Clinical manifestations:
Symptoms vary depending on the drug and pathogenetic mechanism. The autoimmune form (procainamide, hydralazine) may be insidious and chronic, while acute toxic reactions (penicillin, phenylbutazone) tend to present with fever and serous or hemorrhagic pericardial effusion.
Diagnosis:
ECG: ST-segment and T-wave changes.
Echocardiography: assessment of effusion.
Autoimmune tests: ANA, anti-DNA for suspected drug-induced lupus.
Treatment:
Withdrawal of the causative drug.
NSAIDs and colchicine to control inflammation.
Glucocorticoids in severe immune-mediated cases.
References
Imazio M, et al. Management of pericardial diseases. Nat Rev Cardiol. 2020;17(11):693-706.
Adler Y, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921-2964.
LeWinter MM. Clinical practice: pericarditis. N Engl J Med. 2014;371(25):2410-2416.
Maisch B, et al. Pericardial diseases: new insights and unresolved issues. Heart Fail Rev. 2018;23(1):3-14.
Tsang TS, et al. Diagnosis and management of pericardial effusion. Mayo Clin Proc. 2002;77(4):406-413.
Troughton RW, et al. Medical therapy in pericardial disease: an update. Circulation. 2018;137(7):743-754.
Brucato A, et al. Recurrent pericarditis: current perspectives. Clin Cardiol. 2022;45(3):249-258.
Little WC, et al. Pericardial disease. Circ Res. 2015;116(12):1940-1952.
Chow LH, et al. Acute and recurrent pericarditis: modern diagnostic and management strategies. Curr Cardiol Rep. 2021;23(8):95.
Spodick DH. The pericardium: a comprehensive textbook. Marcel Dekker. 1997;1st ed:1-600.